GT Biopharma Announces $16 million in Warrant Exercise Proceeds

Proceeds to Support GTBP Pipeline Drug Development Program BEVERLY HILLS, Calif., July…

GT Biopharma Announces GTB-3550 TriKE(TM) Phase I/II Clinical Trial Update

BEVERLY HILLS, CA / ACCESSWIRE / September 22, 2020 / GT Biopharma,…